Roan Capital Partners’s Oracle ORCL Stock Holding History

Roan Capital Partners’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-190	Closed	-$97K	–	87
2026 Q1	$97K	Buy	+190	New	+$30.9K	0.09%	77

Other funds holding ORCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Roan Capital Partners's ORCL Position: Q2 2026 in Review

Roan Capital Partners sold out of Oracle (ORCL) in Q2 2026, closing a stake of 994 shares — an estimated $146K sold.

Roan Capital Partners first reported a position in ORCL in Q1 2026 and held it in 1 quarter. The position peaked at $146K in Q1 2026. 3,499 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

Roan Capital Partners reported no remaining Oracle position as of Q2 2026 after selling out during the quarter.
Roan Capital Partners sold 994 Oracle shares in Q2 2026, an estimated $146K.
Roan Capital Partners first reported a position in Oracle in Q1 2026 and held it in 1 quarter.
Roan Capital Partners's Oracle position peaked at $146K in Q1 2026.
3,499 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Roan Capital Partners's 13F filing for Q2 2026, filed 9 Jul 2026.